Grants per year
Personal profile
Certifications and Licenses
Internal Medicine | |
Hematology & Oncology |
Training Experience
2010 | Residency, University of Chicago |
2013 | Fellowship, Stanford University Hospitals |
Education/Academic qualification
Medicine, MD, University of Chicago
… → 2007
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Prot #SY-2101-101: An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia
Dinner, S. N. (PD/PI)
Covance Inc., Syros Pharmaceuticals, Inc.
12/16/22 → 12/16/25
Project: Research project
-
Prot #D8241C00001: A Modular Phase I/II, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD0466 Monotherapy or in Combination in Patients with Advanced Haematological Malignancies
Dinner, S. N. (PD/PI)
Parexel, AstraZeneca Pharmaceuticals LP
9/15/22 → 9/15/25
Project: Research project
-
Prot #CYTB323A12101: Phase I, Open Label, Multicenter, Dose Escalation Study of YTB323 in Adult Patients with CLL/SLL and DLBCL
Dinner, S. N. (PD/PI)
Novartis Pharmaceuticals Corporation
2/1/21 → 10/31/27
Project: Research project
-
Prot #UCART123_01: Phase I, Open Label Dose Escalation and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence and Clinical Activity of UCART123 (Allogeneic Engineered T-cells Expressing Anti-CD123 Chimeric Antigen Receptor), Administered
Dinner, S. N. (PD/PI)
11/10/20 → 11/10/26
Project: Research project
-
Prot #ME-522-001 : A Phase 1, Open-Label, Study of Voruciclib in Subjects with Relapsed and/or Refractory B-Cell Malignancies or Acute Myeloid Leukemia After Failure of Prior Standard Therapies
Dinner, S. N. (PD/PI) & Frankfurt, O. (PD/PI)
Medpace Clinical Research LLC, MEI Pharma, Inc.
10/16/20 → 10/26/26
Project: Research project
-
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
Voorhees, P. M., Sborov, D. W., Laubach, J., Kaufman, J. L., Reeves, B., Rodriguez, C., Silbermann, R., Costa, L. J., Anderson, L. D., Nathwani, N., Shah, N., Bumma, N., Efebera, Y. A., Holstein, S. A., Costello, C., Jakubowiak, A., Wildes, T. M., Orlowski, R. Z., Shain, K. H. & Cowan, A. J. & 8 others, , 2025, In: Future Oncology. 21, 1, p. 25-49 25 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Acute Lymphoblastic Leukemia, Version 2.2024
Shah, B., Mattison, R. J., Abboud, R., Abdelmessieh, P., Aldoss, I., Burke, P. W., DeAngelo, D. J., Dinner, S., Fathi, A. T., Gauthier, J., Haddadin, M., Jain, N., Jonas, B., Kirby, S., Liedtke, M., Litzow, M., Logan, A., Long, M., Luger, S. & Mangan, J. K. & 13 others, , Oct 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 8, p. 563-576 14 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia
Burkart, M. & Dinner, S., Jul 2024, In: Blood Reviews. 66, 101208.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
B-ALL in a 21-year-old male with X-linked agammaglobulinemia (XLA): a case report and review of B-cell malignancies in XLA
Franco, S., Fuchs, J., Dinner, S. & Ma, S., 2024, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Litzow, M. R., Sun, Z., Mattison, R. J., Paietta, E. M., Roberts, K. G., Zhang, Y., Racevskis, J., Lazarus, H. M., Rowe, J. M., Arber, D. A., Wieduwilt, M. J., Liedtke, M., Bergeron, J., Wood, B. L., Zhao, Y., Wu, G., Chang, T. C., Zhang, W., Pratz, K. W. & Dinner, S. N. & 22 others, , Jul 25 2024, In: New England Journal of Medicine. 391, 4, p. 320-333 14 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations